Medical Director, Medical Affairs (Lifecycle Management)

• Responsible for protocol design and execution across late-stage clinical research trials in neurologic disorders

• Serve as the LCM Lead for multiple programs, including leadership of the subteams of those programs

• Direct authorship contributions in protocols, clinical study reports, study documents, regulatory documents, and external publications

• Provide medical oversight of clinical trial data and medical monitoring (in conjunction with a CRO medical monitoring team) of clinical trials supporting sNDA indications and LCM studies

• Critically review and contribute to regulatory interactions for LCM studies, sNDAs

• Develop LCM plans with cross functional teams and contribute to strategic discussions related to LCM plans and indications

• Develop strategy for Investigator Sponsored Studies (ISS) program with cross functional team members and serve on the ISS review committee as a reviewer

• Responsible for strategy and execution of product specific global expanded access and compassionate use programs in collaboration with the EAP team

• Represent the company to external audiences, including clinical sites, key opinion leaders, and patient advocacy groups

• In collaboration with clinical operations, oversee and coordinate the operational aspects of ongoing projects to ensure that goals of time, cost and quality performance expectation are met

• Ensure that standard operating procedures (SOP) for the LCM team facilitate the development of effective clinical research programs and are compliant with clinical/medical and industry standards

• Identify and develop collaborative relationships with key investigators, and key thought leaders globally. Attend, plan, and oversee lifecycle management clinical advisory boards and investigator meetings, and present at major medical conferences

This is a high impact position with great visibility, and collaboration, across multiple departments and all levels of the Alkermes organization. This position will have critical responsibilities in the medical affairs group involved in the development of therapies for neurology and neuropsychiatric indications across late-stage programs, contributing to Alkermes' LCM efforts in neuroscience.